发明名称 Fc variants with altered binding to FcRn
摘要 The present application relates to optimized IgG immunoglobulin engineering methods for their generation, and their application, particularly for therapeutic purposes.
申请公布号 US9200079(B2) 申请公布日期 2015.12.01
申请号 US200511274065 申请日期 2005.11.14
申请人 Xencor, Inc. 发明人 Chamberlain Aaron Keith;Desjarlais John R.;Karki Sher Bahadur;Lazar Gregory Alan;Vielmetter Jost;Yoder Sean Christopher
分类号 C07K16/00;C12P21/08;A61K39/395;C07K16/32;C07K16/28;C07K1/00 主分类号 C07K16/00
代理机构 Morgan, Lewis & Bockius, LLP 代理人 Talukder Gargi;Silva Robin M.;Morgan, Lewis & Bockius, LLP
主权项 1. A polypeptide comprising a variant Fc region as compared to a parent Fc polypeptide, said variant Fc region comprising an amino acid substitution at position 308, wherein said amino acid substitution is selected from the group consisting of a phenylalanine, a cysteine, a tyrosine and a tryptophan, wherein said polypeptide has increased in vivo half-life as compared to a polypeptide comprising said parent Fc polypeptide, wherein said polypeptide is selected from the group consisting of an antibody and an immunoadhesin and wherein numbering is according to the EU Index in Kabat et al.
地址 Monrovia CA US